Manhasset, NYNCT04515810Now EnrollingIRB Ready

Locally Advanced Malignant Solid Neoplasm Clinical Trial in Manhasset, NY

Access cutting-edge locally advanced malignant solid neoplasm treatment through this clinical trial at a research site in Manhasset. Study-provided care at no cost to qualified participants.

Sponsored by Fred Hutchinson Cancer Center

Quick Self-Assessment

See if you qualify for this Manhasset location

Preparing your pre-screening questions…

Expert Care in Manhasset

Access locally advanced malignant solid neoplasm specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related locally advanced malignant solid neoplasm treatment provided free

Apply for This Manhasset Location

Check if you qualify for this locally advanced malignant solid neoplasm clinical trial in Manhasset, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Manhasset

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Manhasset site if eligible
  4. 4Begin participation

About This Locally Advanced Malignant Solid Neoplasm Study in Manhasset

This clinical trial tests a new mobile health application (app) called Planning Advance Care Together (PACT) to help people with cancer talk about and plan for advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors. The development of the PACT mobile app may help future patients incorporate their social network (typically, but not exclusively, family) into the advance care planning process.

Sponsor: Fred Hutchinson Cancer Center

Who Can Participate

Inclusion Criteria

PATIENT: Diagnosis of poor prognosis advanced cancer defined as locally advanced or metastatic solid cancer and/or disease progression following at least first line systemic therapy and/or relapsed or refractory hematologic cancer.
PATIENT: Have internet access through a computer or a mobile device; the principal investigator (PI) will ensure that those who have access to a computer or mobile device have access to a computer or mobile device with internet access to ensure they can complete study procedures.
PATIENT: The ability to provide informed consent.
PATIENT: Identification of a loved support person if one is available; patients who are unable to identify a support person willing to participate with them will be allowed to continue in the study on their own.
PATIENT: 18 years of age or older.
SUPPORT PERSON: The person (family member or friend) whom the patient indicates being a support person.
SUPPORT PERSON: English speaking.
SUPPORT PERSON: 18 years of age or older and able to provide informed consent.
PROVIDER: Current clinical practice and/or research with advanced cancer patients.
PROVIDER: A history of 3+ years working with advanced cancer patients.
PROVIDER: 18 years of age or older. Providers across disciplines (e.g., social work, oncology) will be enrolled.

Exclusion Criteria

PATIENT: Not fluent in English.
PATIENT: Severely cognitively impaired (as measured by Short Portable Mental Status Questionnaire scores of \>= 6) to be delivered by trained study research staff during screening.
PATIENT: Too ill or weak to complete the interviews (as judged by the interviewer).
PATIENT: Currently receiving hospice at the time of enrollment.
PATIENT: Children and young adults under age 18.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Manhasset?

Yes, this clinical trial (NCT04515810) has an active research site in Manhasset, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Locally Advanced Malignant Solid Neoplasm Treatment Options in Manhasset, NY

If you're searching for locally advanced malignant solid neoplasm treatment options in Manhasset, NY, this clinical trial (NCT04515810) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Manhasset research site is actively enrolling participants for this clinical trial. You'll receive care from experienced locally advanced malignant solid neoplasm specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all locally advanced malignant solid neoplasm clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in Manhasset, NY

See all leukemia clinical trials recruiting in Manhasset — not just this study.

Browse Leukemia Trials in Manhasset

Ready to Join in Manhasset?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Manhasset, NY